Matthew Rettig

13PUBLICATIONS

197CO-AUTHORS

Predictive and prognostic markersMolecular targetsPharmaceutical delivery technologiesRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 05, 2026

Deep learning models built from PSMA PET of the primary tumor can predict synchronous and metachronous prostate cancer metastases.

|Aug 08, 2024

Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).

Maha Hussain, Masha Kocherginsky, Neeraj Agarwal

|Jul 16, 2024

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.

John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal

|Feb 01, 2024

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer.

Tanya Dorff, Lisa G Horvath, Karen Autio

|Jan 16, 2024

Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide.

Wassim Abida, Andrew W Hahn, Neal Shore

|Aug 28, 2023

Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Soumyajit Roy, Tahmineh Romero, Jeff M Michalski

Pageof 3

Frequent Collaborators

Tomasz M Beer

Joshi J Alumkal

Raunak Shrestha

Jonathan Chou

Felix Y Feng

Martin Sjöström

Arian Lundberg

Thaidy Moreno-Rodriguez

2 joint publications

Adam Foye

2 joint publications

Owen N Witte

Frequent Collaborators

Tomasz M Beer

Joshi J Alumkal

Raunak Shrestha

Jonathan Chou